Physician

Kalim Ahmed, MD

According to 2025 Medicare claims, Kalim Ahmed, MD (NPI: 1194709204) practices pulmonary disease in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is MEDICAL PRACTICES OF ANTIETAM, LLC (NPI: 1558430843; TIN: 522315129) and primary practice location at 21742-2940. Ahmed is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,195 traditional Medicare patients, billed 4,486 HCPCS/CPT codes, and received $285,864 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,759 prescription claims across 382 beneficiaries totaling $642,099 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 4,528 claims. Open Payments data shows 39 records totaling $1,094. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $322,535 to $642,099. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $297,657 and ending at $156,288.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,170	4,679	$379,149
2016	1,339	5,026	$396,593
2017	1,461	5,163	$394,762
2018	1,466	5,058	$378,973
2019	1,445	5,126	$383,426
2020	1,303	4,111	$326,609
2021	1,132	3,766	$307,421
2022	1,383	4,133	$317,063
2023	1,162	3,489	$288,107
2024	1,195	4,486	$285,864

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	1,198	$322,535
2016	278	1,261	$437,651
2017	316	1,390	$614,135
2018	409	2,196	$980,422
2019	435	2,586	$1,221,801
2020	428	2,506	$1,337,266
2021	432	2,370	$1,089,681
2022	441	2,203	$959,886
2023	392	1,603	$730,219
2024	382	1,759	$642,099

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,893	4,982	$300,298
2016	2,101	5,728	$208,515
2017	2,295	6,308	$164,245
2018	2,344	6,110	$172,949
2019	2,525	6,923	$225,720
2020	2,523	6,921	$260,477
2021	2,159	5,732	$229,438
2022	2,036	4,923	$198,716
2023	1,887	4,899	$209,830
2024	1,865	4,528	$157,511

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	745	1,123	$92
94729	Test to examine how well the lungs exchange gases	239	244	$41
94727	Test to determine lung volumes using gas dilution or washout	241	246	$33
94060	Test to measure expiratory airflow and volume changes before and after medication administration	241	246	$28
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	759	1,127	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	132	7,680	$158,559
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	126	5,460	$77,131
Nucala	Mepolizumab	15	420	$55,332
Breo Ellipta	Fluticasone/Vilanterol	85	4,050	$51,641
Incruse Ellipta	Umeclidinium Bromide	84	4,080	$46,465

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	158	300	$24,170
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	46	295	$20,689
E0601	Continuous positive airway pressure (cpap) device	Y	114	605	$17,761
A7031	Face mask interface, replacement for full face mask, each	N	125	293	$17,132
A7032	Cushion for use on nasal mask interface, replacement only, each	N	80	167	$12,275

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,094	Olympus Corporation of the Americas
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kalim Ahmed, MD?

Tedicare shows public-source Medicare data for Kalim Ahmed, MD (NPI 1194709204), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kalim Ahmed, MD have ACO affiliation data?

Kalim Ahmed, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kalim Ahmed, MD?

Kalim Ahmed, MD is linked to MEDICAL PRACTICES OF ANTIETAM, LLC (billing NPI 1558430843) in the available physician profile data.

Does Kalim Ahmed, MD have Open Payments data?

Kalim Ahmed, MD has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.